LIFEPOINT INC
8-A12B, 2000-04-18
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: ONE GROUP INVESTMENT TRUST, 485BXT, 2000-04-18
Next: MONACO COACH CORP /DE/, DEF 14A, 2000-04-18




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   -----------

                                    FORM 8-A


                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                    PURSUANT TO SECTION 12(b) OR 12(g) OF THE
                       SECURITIES AND EXCHANGE ACT OF 1934


                                 LIFEPOINT, INC.
                -------------------------------------------------
             (Exact name of Registrant as specified in Its charter)


                 Delaware                                       33-0539168
   ---------------------------------------                  -------------------
   (State of Incorporation or Organization)                 (I.R.S. Employer
                                                            Identification no.)


   10400 Trademark Street
   Rancho Cucamonga, California                               91730
   (Address of principal executive offices)                  (Zip Code)


   If this form relates to the               If this form relates to the Registr
   registration of a class of securities     -ation of a class of securities
   pursuant to Section 12(b) of the          pursuant to Section 12(g) of the
   Exchange Act and is effective             Exchange Act and is effective
   pursuant to General Instruction           pursuant to General Instruction
   A.(c), please check the following         A.(d), please check the following
   box. |X|                                  |_|


  Securities Act registration statement file number to which
  this form relates:                                               None
                                                                (If applicable)

         Securities to be registered pursuant to Section 12(b) of the Act:

  Title Of Each Class                   Name Of Each Exchange On Which
  To Be So Registered                   Each Class Is To Be Registered
  --------------------                  ------------------------------
  Common Stock, $.001                   The American Stock Exchange LLC



  Securities to be registered pursuant to Section 12(g) of the Act:      None



<PAGE>


                 INFORMATION REQUIRED IN REGISTRATION STATEMENT


Item 1.   Description of Registrant's Securities to be Registered.


       LifePoint,  Inc.  (the  "Company")  has  authorized  3,000,000  shares of
Preferred Stock, $.001 par value (the "Preferred Stock"),  and 50,000,000 shares
of Common  Stock,  $.001 par value  (the  "Common  Stock").  The  Company  seeks
registration  under  Section  12(b) of the  Securities  Exchange Act of 1934, as
amended (the "Exchange Act"),  only as to the Common Stock in order to list such
class of stock on The American Stock Exchange LLC. The Common Stock is currently
registered pursuant to Section 12(g) of the Exchange Act.

       Each  Holder of the  Common  Stock is  entitled  (1) to one vote for each
share held of record,  (2) to notice of any meeting of the  stockholders  of the
Company and (3) to a pro rata share of any dividends as, when and if declared by
the Board of Directors of the Company, subject to any preferential rights of the
then outstanding  shares of the Preferred Stock (of which no series is currently
outstanding).  Upon  liquidation,  dissolution  or winding  up of the  Company's
affairs, each holder of the Common Stock is entitled to share ratably any assets
available for  distribution  after payment of all debts and any  distribution in
respect  of the then  outstanding  shares  of the  Preferred  Stock (of which no
series  is  currently  outstanding).   Holders  of  the  Common  Stock  have  no
pre-emptive,  subscription  or  conversion  rights  and  have  no  sinking  fund
provisions. There are no provisions in the Restated Certificate of Incorporation
or By-Laws of the Company which discriminate against any existing or prospective
holder  of the  Common  Stock  as a  result  of  such  holder's  ownership  of a
substantial  amount of the Common Stock.  All  outstanding  shares of the Common
Stock are fully paid and  nonassessable and all shares of the Common Stock to be
issued in the  future  will be fully  paid and  nonassessable  if (1) the entire
amount of the  consideration  given for such shares,  as authorized  pursuant to
Section 153 of the General Corporation Law of the State of Delaware (the "GCL"),
has  been  received  by the  Company  in the form of  cash,  services  rendered,
personal  property,  real property,  leases of real  property,  or a combination
thereof or (2) not less than the amount of the  consideration  determined  to be
capital  pursuant to Section 154 of the GCL has been  received by the Company in
such form and the Company has received a binding obligation of the subscriber or
purchaser to pay the balance of the subscription or purchase price. There are no
restrictions on the  alienability of the Common Stock other than those which may
be imposed by the Securities Act of 1933, as amended, on particular shares.

       The Restated  Certificate of  Incorporation  provides for the issuance of
3,000,000 shares of the Preferred  Stock.  600,000 of such shares were initially
designated  as the  Series A 10%  Cumulative  Convertible  Preferred  Stock (the
"Series A Preferred  Stock").  All shares of the Series A  Preferred  Stock have
been  converted  into  shares  of  the  Common  Stock,  either  pursuant  to the
conversion  provisions  thereof or pursuant to the  mandatory  redemption by the
Company  on March 24,  2000.  All  shares  of the  Series A  Preferred  Stock so
converted  or  redeemed  have been  restored  to the  status of  authorized  but
unissued shares of the Preferred Stock not constituting part of any series.  The
Board of  Directors of the Company is  authorized  to  designate  the  remaining
series,  to determine the number of shares of the Preferred Stock in each series
and to fix the powers,  preferences and rights of the shares of each such series
and the qualifications,  limitations or restrictions thereof.  Accordingly,  the
Board could,  without the approval of the holders of the Common  Stock,  issue a
new series of the Preferred  Stock with voting and  conversion  rights which may
adversely affect the voting power of the holders of the Common Stock.

       There  are  currently  no  provisions  in  the  Restated  Certificate  of
Incorporation  or the  By-Laws  of the  Company  that  may have  the  effect  of
delaying,  deferring  or  preventing a change in control of the Company and that
would operate with respect to an extraordinary  corporate  transaction involving
the Company,  such as a merger,  a  reorganization,  a tender  offer,  a sale or
transfer of substantially all of its assets, or liquidation.  However, the Board
of Directors of the Company could, without stockholder approval, authorize a new
series of the Preferred Stock with one or more provisions  having the effect, or
operating in the manner, described in the preceding sentence, but has no current
intention to do so.

       Holders of the Common Stock have no cumulative voting rights and there is
no  classification  of the Board of  Directors,  which  means that  stockholders
owning more than 50% of the  outstanding  shares of the Common Stock can vote to
elect all directors and, in such event, the holders of the remaining shares will
not be able to elect any of the Company's directors.

       Dividend payments on the Common Stock are discretionary with the Board of
Directors  of the  Company  and will depend on various  factors,  including  the
Company's earnings,  its capital  requirements,  its financial condition and the
status of dividends on any shares of the Preferred  Stock then  outstanding  (of
which no  series is  currently  outstanding).  The  Company  has  never  paid or
declared  any  dividends  on the Common  Stock.  Based upon the Board's  current
intention of using funds for completion of the product  development  program and
bringing its first  product to market and the current  operational  losses,  the
Company does not  contemplate  or anticipate  paying any dividends on the Common
Stock in the foreseeable future.

       The  Transfer   Agent  for  the  Common  Stock  is  U.S.  Stock  Transfer
Corporation, 1745 Gardena Avenue, Suite 200, Glendale, CA 91204.

Item 2.   Exhibits.

       The  following  exhibits  are  incorporated  herein by  reference  to the
Company's Annual Report on Form 10-K for the fiscal year ended March 31, 1999:

Number   Exhibit
- ------   -------

3(a)     Copy of Restated Certificate of Incorporation of the Company as filed
         in Delaware on April 29, 1999.

3(b)     Copy of By-Laws of the Company as adopted in February 26, 1999.




<PAGE>


                                   SIGNATURES


       Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized.




                                                        LIFEPOINT, INC.
                                                         (Registrant)


Date:  April 18, 2000             By: /s/ Linda H. Masterson
                                     ------------------------------------------
                                           Linda H. Masterson
                                           President and Chief Executive Officer





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission